FDA, CDC Recommend Pausing Johnson & Johnson Vaccine Due To ‘Extremely Rare’ Clots

Six recipients in the U.S. out of more than 6.8 million doses developed a rare disorder involving blood clots about two weeks after getting the J&J shot.Six recipients in the U.S. out of more than 6.8 million doses developed a rare disorder involving blood clots about two weeks after getting the J&J shot.Read More